The global prefilled auto injectors market is undergoing a structural transformation as the center of gravity for biologic drug administration moves from clinical settings to the patient's home. According to the latest strategic analysis by Fact.MR, the market is valued at US$ 5.12 billion in 2026 and is projected to reach US$ 9.70 billion by 2036, expanding at a steady 6.6% CAGR.This...

The United States represents a major market for cardiopulmonary autotransfusion systems, driven by the high volume of cardiovascular and complex surgical procedures performed annually. Strong adoption of patient blood management programs, advanced healthcare infrastructure, and increasing focus on reducing dependence on donor blood continue to support the demand for autotransfusion technologies...